5/31/2013

The FDA approved Sensus Healthcare's SRT-100 superficial radiotherapy system to treat keloids that are the result of medical procedures or injury. The device was approved previously for use with patients whose nonmelanoma skin cancer was not treatable with surgery.

Related Summaries